Revvity (NYSE:RVTY) Trading Down 9.7% – What’s Next?

Shares of Revvity Inc. (NYSE:RVTY) dropped 9.7% during trading on Thursday . The stock traded as low as $86.46 and last traded at $85.1760. Approximately 511,849 shares were traded during mid-day trading, a decline of 59% from the average daily volume of 1,237,861 shares. The stock had previously closed at $94.28.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on the stock. Wells Fargo & Company raised their price target on shares of Revvity from $107.00 to $110.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 3rd. Jefferies Financial Group raised their price target on shares of Revvity from $100.00 to $105.00 and gave the company a “hold” rating in a research note on Monday, February 2nd. Evercore raised their price target on shares of Revvity from $112.00 to $118.00 and gave the company an “outperform” rating in a research note on Tuesday, February 3rd. Wall Street Zen downgraded shares of Revvity from a “buy” rating to a “hold” rating in a research note on Saturday, April 18th. Finally, Weiss Ratings downgraded shares of Revvity from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday, March 18th. Four investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $110.17.

Revvity Trading Down 9.9%

The firm’s 50-day moving average is $91.68 and its 200 day moving average is $97.01. The company has a current ratio of 1.68, a quick ratio of 1.40 and a debt-to-equity ratio of 0.36. The firm has a market capitalization of $9.49 billion, a price-to-earnings ratio of 40.66, a P/E/G ratio of 2.01 and a beta of 1.13.

Revvity (NYSE:RVTY) last posted its earnings results on Monday, February 2nd. The company reported $1.70 EPS for the quarter, topping the consensus estimate of $1.55 by $0.15. Revvity had a net margin of 8.45% and a return on equity of 7.92%. The business had revenue of $772.06 million for the quarter, compared to the consensus estimate of $759.81 million. During the same period last year, the company earned $1.42 EPS. The firm’s revenue was up 5.9% compared to the same quarter last year. Revvity has set its FY 2026 guidance at 5.350-5.450 EPS. On average, equities analysts predict that Revvity Inc. will post 5.39 earnings per share for the current fiscal year.

Revvity Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 8th. Investors of record on Friday, April 17th will be given a dividend of $0.07 per share. The ex-dividend date is Friday, April 17th. This represents a $0.28 annualized dividend and a yield of 0.3%. Revvity’s dividend payout ratio (DPR) is currently 13.46%.

Institutional Investors Weigh In On Revvity

Hedge funds have recently added to or reduced their stakes in the business. New York Life Investment Management LLC boosted its position in Revvity by 72.7% during the 3rd quarter. New York Life Investment Management LLC now owns 27,520 shares of the company’s stock worth $2,412,000 after buying an additional 11,583 shares during the period. Tudor Investment Corp ET AL acquired a new position in shares of Revvity in the 3rd quarter worth approximately $15,128,000. JPMorgan Chase & Co. lifted its position in shares of Revvity by 15.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 511,360 shares of the company’s stock worth $44,821,000 after purchasing an additional 67,662 shares during the period. Campbell & CO Investment Adviser LLC acquired a new position in shares of Revvity in the 3rd quarter worth approximately $905,000. Finally, SG Americas Securities LLC lifted its position in shares of Revvity by 531.8% in the 3rd quarter. SG Americas Securities LLC now owns 42,947 shares of the company’s stock worth $3,764,000 after purchasing an additional 36,149 shares during the period. 86.65% of the stock is currently owned by institutional investors and hedge funds.

About Revvity

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.